CCMS: A New Era in Toxicoproteomics
Capture Compound Mass Spectrometry (CCMS) represents a powerful
platform technology for the generic identification of a drug’s mode
of action, as well as the prediction of potential off-targets responsible
for adverse side effects.
By Friedrich Kroll, Mirko Glinski, Mathias Dreger, Erik Dulsner and Hubert Koster at caprotec GmbH (July 2009)
Keywords: toxicoproteomics, CCMS, platform technology, side effects, in vitro, compound